The most striking passages from The Lancet's scathing review of RFK Jr.’s first 'year of failure'
Industry Buzz
The destruction that Kennedy has wrought in 1 year might take generations to repair, and there is little hope for US health and science while he remains at the helm.
—Editorial authors, The Lancet
For physicians who follow health policy, it’s not every day that a major medical journal openly rebukes a sitting health official. That’s what makes a recent editorial in The Lancet so striking: its blunt headline—“Robert F Kennedy Jr: 1 year of failure.”[]
The journal has rarely published editorials focused on a single public official in such direct terms, which is partly why the piece has sparked such intense conversation across the medical and public health communities.
For clinicians, the debate isn’t just political—it touches the agencies, research pipelines, and public health messaging that shape daily patient care.
If you haven't had a chance to read the letter in its entirety, keep reading: We’ve pulled several of the most striking passages, along with the key policy and research issues the journal argues could have lasting consequences for US health agencies.
The Lancet’s unusually blunt assessment
The Lancet editorial argues that Kennedy has “made a habit of throwing good money after bad science,” claiming that many of his actions contradict promises to restore transparency and “gold standard” evidence-based policy.
Among the examples, the editorial cites:
Dismissing scientific advisers and firing whistleblowers within federal health agencies
Canceling research programs at the National Institutes of Health (NIH) examining the health effects of air pollution
Withholding a federal report linking alcohol consumption to cancer
Withdrawing warnings from the Food and Drug Administration about pseudoscientific autism treatments
Changes at the Centers for Disease Control and Prevention that reportedly led 26 states to reject federal guidance on vaccine policy
The editorial also highlights a controversial research initiative: a $1.6 million grant to conduct a hepatitis B vaccine study in Guinea-Bissau. According to the journal, the study, which would have been conducted by a research group described as sympathetic to anti-vaccine views, was ultimately canceled by officials in the host country over ethical concerns.
Taken together, the editors argue that the cumulative effect of these moves could be long-lasting.
“The destruction that Kennedy has wrought in 1 year might take generations to repair, and there is little hope for US health and science while he remains at the helm,” the editorial concludes.
Opinions from the scientific community
This editorial didn’t emerge in isolation. According to critics, it reflects a broader pattern of concern from across the biomedical world.
Jessica Knurick, PhD, RDN, recently highlighted the editorial in a viral Instagram Reel: “That is not normal. They do not do that,” she said, emphasizing that a direct editorial condemnation of a cabinet-level health official is extremely rare.
Dr. Knurick also pointed to other public statements raising alarms about scientific standards at HHS, including:
A letter signed by 77 Nobel laureates
Statements from six former US surgeons general spanning both Republican and Democratic administrations
Concerns voiced by major medical organizations
An open letter signed by more than 1,000 current and former HHS employees
What it could mean for clinicians
For physicians, the stakes are practical. Federal agencies like the NIH, CDC, and FDA shape everything from clinical guidelines and surveillance data to research funding and drug safety communications.
You're familiar with the argument by now, certainly, but it's worth the refresher.
You're familiar with the argument by now, certainly, but it's worth the refresher—the most consequential impacts include the following:
1. Vaccine guidance: If states diverge from federal recommendations—as some already have—physicians face greater variability in public health messaging and patient expectations.
2. Research funding: Cuts or cancellations of major NIH programs ripple through academic medicine, slowing new evidence generation in areas like environmental health.
3. Public trust: When federal health messaging becomes contested, clinicians often become the front line for patient questions about vaccines, treatments, or emerging risks.
A call for congressional oversight
The editorial ultimately calls on Congress to step in. The Lancet’s editors argue that lawmakers have a responsibility to exercise oversight of HHS and hold leadership accountable for decisions affecting national health policy.
Whether that oversight leads to policy changes—or simply intensifies the political debate—remains to be seen.
For now, the editorial underscores how closely the scientific community is watching federal health leadership.
And for practicing physicians, it’s another reminder that the intersection of politics, public health, and science can shape the clinical landscape in ways that reach far beyond Washington.